Evidence map›Paper›PMID 27992415›Full record

ArticleNature genetics2017

A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

Ryan J Park, Tim Wang, Dylan Koundakjian, Judd F Hultquist, Pedro Lamothe-Molina, Blandine Monel, Kathrin Schumann, Haiyan Yu, Kevin M Krupzcak, Wilfredo Garcia-Beltran and 7 more

Abstract read
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 205 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 3 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 3 syntheses or guidelines pooled it, 338 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. CypA is a molecular barrier to HIV emergence from Eastern chimpanzees.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Identifying genetic loci associated with drought tolerance in foxtail millet (Setaria italica).TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Article
  13. Article
  14. Review
  15. BeyondFrontiers in genetics · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Ryan J ParkRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Tim WangBroad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA.
Dylan KoundakjianRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Judd F HultquistDepartment of Cellular and Molecular Pharmacology, California Institute for Quantitative Biosciences, QB3, University of California at San Francisco (UCSF), San Francisco, California, USA.
Pedro Lamothe-MolinaRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Blandine MonelRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Kathrin SchumannDepartment of Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA.
Haiyan YuBroad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA.
Kevin M KrupzcakWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
Wilfredo Garcia-BeltranRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Alicja Piechocka-TrochaRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Nevan J KroganDepartment of Cellular and Molecular Pharmacology, California Institute for Quantitative Biosciences, QB3, University of California at San Francisco (UCSF), San Francisco, California, USA.
Alexander MarsonDepartment of Microbiology and Immunology, University of California at San Francisco, San Francisco, California, USA.
David M SabatiniBroad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA.
Eric S LanderBroad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA.
Nir HacohenBroad Institute of MIT and Harvard University, Cambridge, Massachusetts, USA.
Bruce D WalkerRagon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT), and Harvard University, Cambridge, Massachusetts, USA.
Harvard University · USRagon Institute of MGH, MIT and Harvard · USBroad Institute · USGladstone Institutes · USHoward Hughes Medical Institute · USInnovative Genomics Institute · USKoch Institute for Integrative Cancer Research At MIT · USUniversity of California, San Francisco · USWhitehead Institute for Biomedical Research · US

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
Virus CoreU19AI106754 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALBRECHT, RANDY A. · 2013 to 2017
$26.0M
Molecular Virology and Systems Biology Screening CoreP01AI090935 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KOENIG, RENATE · 2010 to 2014
$20.4M
Regulation of the mTOR Pathway By NutrientsR01CA103866 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI WEISSMAN, JONATHAN S. · 2004 to 2021
$7.0M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Identifying the ligand for the activating NK cell receptor KIR3DS1 and its protective role in HIV-1 disease progressionF31AI116366 · NIAID · HARVARD MEDICAL SCHOOL · PI GARCIA-BELTRAN, WILFREDO F · 2015 to 2018
$157k
Improving targeted therapies through functional genomic approachesF31CA189437 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WANG, TIM · 2014 to 2017
$107k
NCI NIH HHS F31 CA189437NCI NIH HHS R01 CA103866NHGRI NIH HHS U54 HG003067NIAID NIH HHS F31 AI116366NIAID NIH HHS P01 AI090935NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI060354NIAID NIH HHS T32 AI060537NIAID NIH HHS U19 AI106754NIGMS NIH HHS P50 GM082250NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

Host proteins are essential for HIV entry and replication and can be important nonviral therapeutic targets. Large-scale RNA interference (RNAi)-based screens have identified nearly a thousand candidate host factors, but there is little agreement among studies and few factors have been validated. Here we demonstrate that a genome-wide CRISPR-based screen identifies host factors in a physiologically relevant cell system. We identify five factors, including the HIV co-receptors CD4 and CCR5, that are required for HIV infection yet are dispensable for cellular proliferation and viability. Tyrosylprotein sulfotransferase 2 (TPST2) and solute carrier family 35 member B2 (SLC35B2) function in a common pathway to sulfate CCR5 on extracellular tyrosine residues, facilitating CCR5 recognition by the HIV envelope. Activated leukocyte cell adhesion molecule (ALCAM) mediates cell aggregation, which is required for cell-to-cell HIV transmission. We validated these pathways in primary human CD4

Indexed as

Activated-Leukocyte Cell Adhesion MoleculeCell LineClustered Regularly Interspaced Short Palindromic RepeatsGenomeHIV-1HIV InfectionsHost-Pathogen InteractionsHumansMembrane ProteinsReceptors, CCR5RNA InterferenceSulfotransferasesVirus ReplicationActivated-Leukocyte Cell Adhesion MoleculeCCR5 protein, humanMembrane ProteinsReceptors, CCR5SulfotransferasesTPST2 protein, human

Identifiers

PMID27992415
PMCPMC5511375
OpenAlexW2565680402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.